Most sold healthcare stocks in Q1 2019
See which Healthcare stocks institutional investors trimmed or exited the most in Q1 2019, measured as net reductions in reported share positions from Q4 2018 into Q1 2019. Notable reductions at the top of this list include TEVA PHARMACEUTICAL-SP ADR (TEVA), MERCK & CO. INC. (MRK), WALGREENS BOOTS ALLIANCE INC (WBA), AMNEAL PHARMACEUTICALS INC (AMRX). These rankings aggregate SEC 13F filings from all institutional investors in our database.
Explore more:
| Symbol | Name | Net shares | Net value | New | Added | Trimmed | Sold out | Holding now |
|---|---|---|---|---|---|---|---|---|
| TEVA | TEVA PHARMACEUTICAL-SP ADR | -4,153,957 | -$46.24M | 1 | 2 | 2 | 0 | 7 |
| MRK | MERCK & CO. INC. | -3,280,308 | -$190.36M | 3 | 1 | 8 | 1 | 16 |
| WBA | WALGREENS BOOTS ALLIANCE INC | -3,149,777 | -$217.48M | 2 | 1 | 3 | 1 | 6 |
| AMRX | AMNEAL PHARMACEUTICALS INC | -2,919,504 | -$39.25M | 0 | 0 | 1 | 1 | 1 |
| WAT | WATERS CORP | -1,582,069 | $53.98M | 1 | 1 | 2 | 1 | 4 |
| CAH | CARDINAL HEALTH INC | -1,234,769 | -$32.39M | 1 | 2 | 3 | 1 | 6 |
| COR | CENCORA INC | -1,159,967 | -$61.35M | 1 | 1 | 2 | 0 | 4 |
| CTLT | CATALENT INC | -918,115 | -$15.47M | 2 | 0 | 2 | 1 | 4 |
| MD | PEDIATRIX MEDICAL GROUP INC | -842,794 | -$45.27M | 0 | 1 | 1 | 0 | 2 |
| TGTX | TG THERAPEUTICS INC | -829,800 | -$3.22M | 0 | 0 | 1 | 0 | 1 |
| SRNE | SORRENTO THERAPEUTICS INC | -806,763 | -$1.79M | 0 | 0 | 0 | 1 | 1 |
| CI | THE CIGNA GROUP | -667,181 | -$550.74M | 2 | 2 | 1 | 1 | 5 |
| NVS | NOVARTIS AG-SPONSORED ADR | -638,534 | $363.56M | 1 | 2 | 4 | 0 | 10 |
| TNDM | TANDEM DIABETES CARE INC | -637,900 | -$4.45M | 0 | 0 | 1 | 0 | 1 |
| EXAS | EXACT SCIENCES CORP | -614,787 | $39.89M | 2 | 0 | 1 | 0 | 3 |
| ACAD | ACADIA PHARMACEUTICALS INC | -597,800 | -$9.67M | 0 | 0 | 0 | 1 | 0 |
| NTRA | NATERA INC | -563,200 | -$2.72M | 0 | 0 | 1 | 0 | 1 |
| HOLX | HOLOGIC INC | -551,610 | $97.07M | 1 | 1 | 2 | 1 | 5 |
| BPMC | BLUEPRINT MEDICINES CORP | -541,661 | -$11.98M | 0 | 0 | 1 | 0 | 1 |
| STAA | STAAR SURGICAL CO | -517,306 | -$14.78M | 1 | 0 | 1 | 0 | 2 |
| CLSD | CLEARSIDE BIOMEDICAL INC | -479,707 | -$505.00K | 0 | 0 | 1 | 0 | 1 |
| MRNA | MODERNA INC | -413,298 | $78.36M | 0 | 0 | 1 | 0 | 1 |
| CARA | CARA THERAPEUTICS INC | -407,641 | $347.00K | 0 | 1 | 0 | 1 | 1 |
| NEO | NEOGENOMICS INC | -402,700 | -$5.08M | 0 | 0 | 0 | 1 | 0 |
| HUM | HUMANA INC | -389,948 | -$175.57M | 1 | 0 | 1 | 0 | 2 |
| UNH | UNITEDHEALTH GROUP INC | -388,111 | -$138.52M | 2 | 6 | 5 | 0 | 17 |
| IDXX | IDEXX LABORATORIES INC | -342,357 | -$133.53M | 0 | 1 | 2 | 0 | 5 |
| VREX | VAREX IMAGING CORP | -334,806 | $3.16M | 0 | 0 | 2 | 0 | 2 |
| RMD | RESMED INC | -304,909 | -$34.89M | 1 | 0 | 0 | 1 | 1 |
| MOH | MOLINA HEALTHCARE INC | -275,724 | $63.55M | 1 | 0 | 1 | 0 | 2 |
| ANIK | ANIKA THERAPEUTICS INC | -266,440 | -$10.21M | 1 | 1 | 0 | 1 | 2 |
| INGN | INOGEN INC | -260,480 | -$40.30M | 1 | 1 | 1 | 0 | 3 |
| AMGN | AMGEN INC | -256,391 | -$71.44M | 1 | 2 | 4 | 0 | 9 |
| MEDP | MEDPACE HOLDINGS INC | -229,391 | -$10.58M | 1 | 0 | 1 | 0 | 2 |
| GRFS | GRIFOLS SA-ADR | -229,039 | $17.14M | 1 | 1 | 1 | 0 | 3 |
| FMS | FRESENIUS MEDICAL CARE-ADR | -221,400 | -$6.94M | 0 | 0 | 1 | 0 | 1 |
| PODD | INSULET CORP | -217,591 | -$17.26M | 1 | 0 | 0 | 1 | 1 |
| ARDX | ARDELYX INC | -217,119 | $1.61M | 0 | 0 | 1 | 0 | 1 |
| THC | TENET HEALTHCARE CORP | -212,475 | -$3.64M | 0 | 0 | 0 | 1 | 0 |
| ISRG | INTUITIVE SURGICAL INC | -198,593 | -$47.67M | 1 | 2 | 1 | 1 | 5 |
| CDMO | AVID BIOSERVICES INC | -196,827 | -$773.00K | 0 | 0 | 1 | 0 | 1 |
| NKTR | NEKTAR THERAPEUTICS | -192,608 | -$6.18M | 1 | 0 | 1 | 0 | 2 |
| ATEC | ALPHATEC HOLDINGS INC | -189,600 | -$344.00K | 0 | 0 | 1 | 0 | 1 |
| PBYI | PUMA BIOTECHNOLOGY INC | -185,700 | -$2.08M | 0 | 0 | 1 | 0 | 1 |
| MASI | MASIMO CORP | -181,658 | $6.51M | 0 | 2 | 1 | 0 | 3 |
| VCYT | VERACYTE INC | -160,342 | $46.67M | 0 | 0 | 2 | 0 | 2 |
| LLY | ELI LILLY & CO | -160,313 | $209.38M | 1 | 3 | 2 | 1 | 6 |
| TECH | BIO-TECHNE CORP | -156,187 | $66.51M | 1 | 0 | 2 | 0 | 3 |
| IART | INTEGRA LIFESCIENCES HOLDING | -148,360 | -$6.69M | 0 | 0 | 0 | 1 | 0 |
| ENTA | ENANTA PHARMACEUTICALS INC | -147,705 | $5.57M | 1 | 0 | 1 | 0 | 2 |
Frequently asked questions about Most sold healthcare stocks in Q1 2019
What are the most sold Healthcare stocks in Q1 2019?
The most sold healthcare stocks in Q1 2019 are those with the largest decrease in reported share counts across institutional investors compared to Q4 2018, based on SEC 13F filings.
Which healthcare stocks did institutional investors trimmed or exited the most in Q1 2019?
Among filers in this sector, net reductions were largest in companies such as TEVA PHARMACEUTICAL-SP ADR (TEVA), MERCK & CO. INC. (MRK), WALGREENS BOOTS ALLIANCE INC (WBA), based on aggregated 13F data.
How is institutional selling calculated?
Selling is calculated by summing the net decrease in shares reported by institutional investors between two consecutive quarterly 13F snapshots (compared to Q4 2018).
Does this include all institutional owners?
Yes. These rankings aggregate SEC 13F filings from all institutional investors in our database, not only the investors we track individually.
Are these trades real-time?
No. 13F filings are reported quarterly and may be delayed by up to 45 days. The data reflects positions at the end of the reporting period, not real-time trading activity.